Selenium attenuates high glucose-induced ROS/TLR-4 involved apoptosis of rat cardiomyocyte

Biological Trace Element Research

Volumn 156, Issue 1-3, 2013, Pages 262-270

  Liu, Zhong Wei ^a   Zhu, Hai Tao ^a   Chen, Kun Lun ^a   Qiu, Chuan ^b   Tang, Kai Fa ^c   Niu, Xiao Lin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b TULANE UNIVERSITY   (United States)

^c GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; High glucose; Reactive oxygen species; Selenium; Toll like receptor 4

Indexed keywords

CASPASE 3; CASPASE 8; GLUCOSE; GLUTATHIONE PEROXIDASE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; REACTIVE OXYGEN METABOLITE; SELENIUM; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANTIAPOPTOTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ATTENUATION; CELL ISOLATION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MODIFICATION; GENE EXPRESSION; HEART MUSCLE CELL; HYPERGLYCEMIA; MALE; MYD 88 GENE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; RAT; SIGNAL TRANSDUCTION; TLR 4 GENE; UPREGULATION;

RATTUS;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 8; GLUCOSE; MALE; MYELOID DIFFERENTIATION FACTOR 88; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SELENIUM; SIGNAL TRANSDUCTION; SWEETENING AGENTS; TOLL-LIKE RECEPTOR 4;

EID: 84890793249     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-013-9857-7     Document Type: Article

References (47)

1. Francis GS (2001) Diabetic cardiomyopathy: fact or fiction? Heart 85(3):247-248
2. Battiprolu PK, Gillette TG, Wang ZV, Lavandero S, Hill JA (2010) Diabetic cardiomyopathy: mechanisms and therapeutic targets. Drug Discov Today Dis Mech 7(2):e135-e143. doi: 10.1016/j.ddmec.2010.08.001
3. Fang ZY, Prins JB, Marwick TH (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25(4):543-567. doi: 10.1210/er.2003-0012
4. Cai L, Kang YJ (2001) Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol 1(3):181-193
5. Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, Kang YJ (2006) Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol 48(8):1688-1697. doi: 10.1016/j.jacc.2006.07.022
6. Cai L, Kang YJ (2003) Cell death and diabetic cardiomyopathy. Cardiovasc Toxicol 3(3):219-228
7. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ (2002) Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105(10):1158-1161
8. Oyama J, Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA, Bourcier T (2004) Reduced myocardial ischemia-reperfusion injury in Toll-like receptor 4-deficient mice. Circulation 109(6):784-789. doi: 10.1161/01.CIR.0000112575.66565.84
9. Thomas JA, Tsen MF, White DJ, Horton JW (2002) TLR4 inactivation and rBPI(21) block burn-induced myocardial contractile dysfunction. Am J Physiol Heart Circ Physiol 283(4):H1645-H1655. doi: 10.1152/ajpheart.01107.2001
10. Ha T, Li Y, Hua F, Ma J, Gao X, Kelley J, Zhao A, Haddad GE, Williams DL, William Browder I, Kao RL, Li C (2005) Reduced cardiac hypertrophy in Toll-like receptor 4-deficient mice following pressure overload. Cardiovasc Res 68(2):224-234. doi: 10.1016/j.cardiores.2005.05.025
11. Riad A, Bien S, Gratz M, Escher F, Westermann D, Heimesaat MM, Bereswill S, Krieg T, Felix SB, Schultheiss HP, Kroemer HK, Tschope C (2008) Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice. Eur J Heart Fail 10(3):233-243. doi: 10.1016/j.ejheart.2008.01.004
12. Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E (2004) Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 172(4):2522-2529
13. Sarir H, Mortaz E, Karimi K, Kraneveld AD, Rahman I, Caldenhoven E, Nijkamp FP, Folkerts G (2009) Cigarette smoke regulates the expression of TLR4 and IL-8 production by human macrophages. J Inflamm (London) 6:12. doi: 10.1186/1476-9255-6-12
14. Stadtman TC (1991) Biosynthesis and function of selenocysteine-containing enzymes. J Biol Chem 266(25):16257-16260
15. Dursun N, Taskin E, Yerer Aycan MB, Sahin L (2011) Selenium-mediated cardioprotection against adriamycin-induced mitochondrial damage. Drug Chem Toxicol 34(2):199-207. doi: 10.3109/01480545.2010.538693
16. Aydemir-Koksoy A, Bilginoglu A, Sariahmetoglu M, Schulz R, Turan B (2010) Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress. J Nutr Biochem 21(9):827-833. doi: 10.1016/j.jnutbio.2009.06.006
17. Zuo L, Youtz DJ, Wold LE (2011) Particulate matter exposure exacerbates high glucose-induced cardiomyocyte dysfunction through ROS generation. PloS one 6(8):e23116. doi: 10.1371/journal.pone.0023116
18. Privratsky JR, Wold LE, Sowers JR, Quinn MT, Ren J (2003) AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension 42(2):206-212. doi: 10.1161/01.HYP.0000082814.62655.85
19. Zhou YJ, Zhang SP, Liu CW, Cai YQ (2009) The protection of selenium on ROS mediated-apoptosis by mitochondria dysfunction in cadmium-induced LLC-PK(1) cells. Tox in Vitro Int J Publ Assoc BIBRA 23(2):288-294. doi: 10.1016/j.tiv.2008.12.009
20. Potnis PA, Dutta DK, Wood SC (2013) Toll-like receptor 4 signaling pathway mediates proinflammatory immune response to cobalt-alloy particles. Cell Immunol 282(1):53-65. doi: 10.1016/j.cellimm.2013.04.003
21. Lv J, Jia R, Yang D, Zhu J, Ding G (2009) Candesartan attenuates Angiotensin II-induced mesangial cell apoptosis via TLR4/MyD88 pathway. Biochem Biophys Res Commun 380(1):81-86. doi: 10.1016/j.bbrc.2009.01.035
22. Aksakal E, Akaras N, Kurt M, Tanboga IH, Halici Z, Odabasoglu F, Bakirci EM, Unal B (2011) The role of oxidative stress in diabetic cardiomyopathy: an experimental study. Eur Rev Med Pharmacol Sci 15(11):1241-1246
23. Yu T, Sheu SS, Robotham JL, Yoon Y (2008) Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc Res 79(2):341-351. doi: 10.1093/cvr/cvn104
24. Chao W (2009) Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol 296(1):H1-H12. doi: 10.1152/ajpheart.00995.2008
25. Zhao P, Wang J, He L, Ma H, Zhang X, Zhu X, Dolence EK, Ren J, Li J (2009) Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemia. J Cell Mol Med 13(8A):1513-1525. doi: 10.1111/j.1582-4934.2009.00798.x
26. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11(1):115-122
27. Ha T, Hua F, Li Y, Ma J, Gao X, Kelley J, Zhao A, Haddad GE, Williams DL, Browder IW, Kao RL, Li C (2006) Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol 290(3):H985-H994. doi: 10.1152/ajpheart.00720.2005
28. Han KJ, Su X, Xu LG, Bin LH, Zhang J, Shu HB (2004) Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. J Biol Chem 279(15):15652-15661. doi: 10.1074/jbc. M311629200
29. Benchoua A, Couriaud C, Guegan C, Tartier L, Couvert P, Friocourt G, Chelly J, Menissier-de Murcia J, Onteniente B (2002) Active caspase-8 translocates into the nucleus of apoptotic cells to inactivate poly(ADP-ribose) polymerase-2. J Biol Chem 277(37):34217-34222. doi: 10.1074/jbc.M203941200
30. Zhang Y, Peng T, Zhu H, Zheng X, Zhang X, Jiang N, Cheng X, Lai X, Shunnar A, Singh M, Riordan N, Bogin V, Tong N, Min WP (2010) Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of Toll-like receptor-4. J Trans Med 8:133. doi: 10.1186/1479-5876-8-133
31. Powers KA, Szaszi K, Khadaroo RG, Tawadros PS, Marshall JC, Kapus A, Rotstein OD (2006) Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J Exp Med 203(8):1951-1961. doi: 10.1084/jem.20060943
32. Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I (2008) High glucose induces Toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 57(11):3090-3098. doi: 10.2337/db08-0564
33. Huang D, Fang F, Xu F (2011) Hyperoxia-induced up-regulation of Toll-like receptors expression in alveolar epithelial cells. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 23(11):645-649, Chinese Critical Care Med Zhongguo Weizhongbing Jijiuyixue
34. Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S, Koyasu S, Matsumoto K, Takeda K, Ichijo H (2005) ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 6(6):587-592. doi: 10.1038/ni1200
35. Nakahira K, Kim HP, Geng XH, Nakao A, Wang X, Murase N, Drain PF, Sasidhar M, Nabel EG, Takahashi T, Lukacs NW, Ryter SW, Morita K, Choi AM (2006) Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp Med 203(10):2377-2389. doi: 10.1084/jem.20060845
36. Ho FM, Liu SH, Liau CS, Huang PJ, Lin-Shiau SY (2000) High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation 101(22):2618-2624
37. Wang GW, Klein JB, Kang YJ (2001) Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome C release and caspase-3 activation in cardiomyocytes. J Pharmacol Exp ther 298(2):461-468
38. Balteau M, Tajeddine N, de Meester C, Ginion A, Des Rosiers C, Brady NR, Sommereyns C, Horman S, Vanoverschelde JL, Gailly P, Hue L, Bertrand L, Beauloye C (2011) NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1. Cardiovasc Res 92(2):237-246. doi: 10.1093/cvr/cvr230
39. Fiordaliso F, Bianchi R, Staszewsky L, Cuccovillo I, Doni M, Laragione T, Salio M, Savino C, Melucci S, Santangelo F, Scanziani E, Masson S, Ghezzi P, Latini R (2004) Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. J Mol Cell Cardiol 37(5):959-968. doi: 10.1016/j.yjmcc.2004.07.008
40. Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ (2002) Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 51(6):1938-1948
41. Venardos K, Ashton K, Headrick J, Perkins A (2005) Effects of dietary selenium on post-ischemic expression of antioxidant mRNA. Mol Cell Biochem 270(1-2):131-138
42. Liu ZW, Niu XL, Chen KL, Xing YJ, Wang X, Qiu C, Gao DF (2013) Selenium attenuates adriamycin-induced cardiac dysfunction via restoring expression of ATP-sensitive potassium channels in rats. Biol Trace Elem Res 153(1-3):220-228. doi: 10.1007/s12011-013-9641-8
43. Sandstrom BE, Marklund SL (1990) Effects of variation in glutathione peroxidase activity on DNA damage and cell survival in human cells exposed to hydrogen peroxide and t-butyl hydroperoxide. Biochem J 271(1):17-23
44. Demelash A, Karlsson JO, Nilsson M, Bjorkman U (2004) Selenium has a protective role in caspase-3-dependent apoptosis induced by H2O2 in primary cultured pig thyrocytes. Eur J Endocrinol Eur Fed Endocr Soc 150(6):841-849
45. Shi YQ, Chen X, Dai J, Jiang ZF, Li N, Zhang BY, Zhang ZB (2012) Selenium pretreatment attenuates formaldehyde-induced genotoxicity in A549 cell lines. Toxicol Ind health. doi: 10.1177/0748233712466129
46. Miyamoto Y, Koh YH, Park YS, Fujiwara N, Sakiyama H, Misonou Y, Ookawara T, Suzuki K, Honke K, Taniguchi N (2003) Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses. Biol Chem 384(4):567-574. doi: 10.1515/BC.2003.064
47. Shiomi T, Tsutsui H, Matsusaka H, Murakami K, Hayashidani S, Ikeuchi M, Wen J, Kubota T, Utsumi H, Takeshita A (2004) Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 109(4):544-549. doi: 10.1161/01.CIR.0000109701. 77059.E9